Natera
A dynamic Clinical Oncology Specialist joins the newly established Breast Oncology specialty team to accelerate the adoption and growth of Signatera, a groundbreaking MRD ctDNA test. This high-impact, tumor-specific role involves acting as a strategic field partner and key representative of Natera Oncology across integrated delivery networks, academic medical centers, and community oncology practices. The position requires deep clinical acumen and the ability to navigate complex healthcare systems while fostering trusted relationships with key stakeholders.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
100% above the average for this role
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Medical Director, Clinical Development - MRD Portfolio (Solid Tumors)
Labcorp
Medical Director, Clinical Development – MRD Portfolio (Solid Tumors)
Labcorp
Medical Manager – Oncology (Breast Cancer)
AstraZeneca
Executive Sales Director, Precision Oncology
Oracle
Executive Sales Director, Precision Oncology
Oracle
Medical Science Liaison (MSL) – Oncology
Personalis, Inc